Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1979 Sep;37(3):452–456.

T and B lymphocytes in myasthenia gravis.

Y Itoyama, S Kawanami, I Goto, Y Kuroiwa
PMCID: PMC1537772  PMID: 315844

Abstract

Peripheral blood lymphocytes from seventeen non-thymectomized and nine thymectomized patients with myasthenia gravis (MG) and thirteen healthy controls were examined for the presence of surface markers characteristic of T and B lymphocytes by rosette formation with sheep red blood cells (SRBC). T cells were identified by their capacity to spontaneously form rosettes with SRBCs. The percentage of B lymphocytes was determined by the erythrocyte antibody complement (EAC) rosette-forming test. The EAC complex was prepared with either whole rabbit anti-SRBC serum or with the IgM fraction of rabbit anti-SRBC serum. The two kind of erythrocyte complement rosette-forming cells (EAC-RFC) are designated erythrocyte-haemolysin-complement RFC (EA(H)C-RFC), and erythrocyte-IgM-complement RFC (EA(M)C-RFC). The percentage of total lymphocytes and T cells was not altered in MG patients. The percentage of 'active' T cells, which have been considered to be more actively involved in cellular immunity, was also similar in MG patients and controls. A significant increase in EA(H)C-RFC occurred in both thymectomized and non-thymectomized MG patients, while in B cells detected by EA(M)C-RFC no alterations were found. The increase in EA(H)C-RFC in lymphocytes from MG patients may be due to an increase in the 19S antibody-forming B lymphocytes or to an increase in T cells which have Fc receptors on their surface.

Full text

PDF
455

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdou N. I., Lisak R. P., Zweiman B., Abrahamsohn I., Penn A. S. The thymus in myasthenia gravis. Evidence for altered cell populations. N Engl J Med. 1974 Dec 12;291(24):1271–1275. doi: 10.1056/NEJM197412122912403. [DOI] [PubMed] [Google Scholar]
  2. Abramsky O., Aharonov A., Webb C., Fuchs S. Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis. Clin Exp Immunol. 1975 Jan;19(1):11–16. [PMC free article] [PubMed] [Google Scholar]
  3. Alpert L. I., Rule A., Norio M., Kott E., Kornfeld P., Osserman K. E. Studies in myasthenia gravis: cellular hypersensitivity to skeletal muscle. Am J Clin Pathol. 1972 Dec;58(6):647–653. doi: 10.1093/ajcp/58.6.647. [DOI] [PubMed] [Google Scholar]
  4. Bender A. N., Ringel S. P., Engel W. K., Daniels M. P., Vogel Z. Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet. 1975 Mar 15;1(7907):607–609. doi: 10.1016/s0140-6736(75)91886-3. [DOI] [PubMed] [Google Scholar]
  5. Gergely P., Bakács T., Cornain S., Klein E. Fc receptors on human blood B lymphocytes. Clin Exp Immunol. 1977 Apr;28(1):99–102. [PMC free article] [PubMed] [Google Scholar]
  6. Goust J. M., Castaigne A., Moulias R. Delayed hypersensitivity to muscle and thymus in myasthenia gravis and polymyositis. Clin Exp Immunol. 1974 Sep;18(1):39–47. [PMC free article] [PubMed] [Google Scholar]
  7. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jondal M., Wigzell H., Aiuti F. Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev. 1973;16:163–195. doi: 10.1111/j.1600-065x.1973.tb00120.x. [DOI] [PubMed] [Google Scholar]
  9. Kawanami S., Itoyama Y., Kuroiwa Y. Leucocyte migration inhibition in myasthenia gravis. The effect of thymectomy. J Neurol. 1976 Jul 15;213(1):33–40. doi: 10.1007/BF00316337. [DOI] [PubMed] [Google Scholar]
  10. Monnier V. M., Fulpius B. W. A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin Exp Immunol. 1977 Jul;29(1):16–22. [PMC free article] [PubMed] [Google Scholar]
  11. NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
  12. NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
  14. Papatestas A. E., Alpert L. I., Osserman K. E., Osserman R. S., Kark A. E. Studies in myasthenia gravis: effects of thymectomy. Results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941-1969. Am J Med. 1971 Apr;50(4):465–474. doi: 10.1016/0002-9343(71)90336-6. [DOI] [PubMed] [Google Scholar]
  15. Parish C. R. Separation and functional analysis of subpopulations of lymphocytes bearing complement and Fc receptors. Transplant Rev. 1975;25:98–120. doi: 10.1111/j.1600-065x.1975.tb00727.x. [DOI] [PubMed] [Google Scholar]
  16. RUSSELL D. S. Histological changes in the striped muscles in myasthenia gravis. J Pathol Bacteriol. 1953 Apr;65(2):279–289. doi: 10.1002/path.1700650202. [DOI] [PubMed] [Google Scholar]
  17. Simpson J. A. Myasthenia gravis as an autoimmune disease: clinical aspects. Ann N Y Acad Sci. 1966 Jan 26;135(1):506–516. doi: 10.1111/j.1749-6632.1966.tb45499.x. [DOI] [PubMed] [Google Scholar]
  18. Wybran J., Fudenberg H. H. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest. 1973 May;52(5):1026–1032. doi: 10.1172/JCI107267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Yata J., Tsukimoto I., Tachibana T. Human lymphocyte subpopulations. Human thymus-lymphoid tissue (HTL) antigen-positive lymphocytes forming rosettes with sheep erythrocytes and HTL antigen-negative lymphocytes interacting with antigen-antibody-complement complexes. Clin Exp Immunol. 1973 Jul;14(3):319–326. [PMC free article] [PubMed] [Google Scholar]
  20. Yoshida T. O., Andersson B. Evidence for a receptor recognizing antigen complexed immunoglobulin on the surface of activated mouse thymus lymphocytes. Scand J Immunol. 1972;1(4):401–408. doi: 10.1111/j.1365-3083.1972.tb03306.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES